Article Details
Retrieved on: 2022-08-23 11:13:49
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Nasdaq: SYBX), a clinical biotechnology company developing drugs for metabolic and immune diseases through its own approach to synthetic biology, ...
Article found on: www.bollyinside.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here